Speakers

Volker Huppert

Chief Development Officer • GlycoStem

Volker Huppert is a graduate bioprocess engineer from RWTH Aachen University. Among his achievements are participation in the set up of a quality system for a medical device/biotechnology company and the development of several clinical-level reagents, disposable tubing sets and process software for cell separation and cell culture medical devices. He contributed to both the tubing set and process software development of a leading cell therapy-manufacturing device. Additionally, he managed projects and teams developing cell-manufacturing procedures for hematopoietic stem cells and Natural Killer cells. Huppert has published 12 papers in peer-reviewed journals over the past 20 years while working for a leading biotechnology company and is co-inventor of 9 patent families, including methods for T cell depletion of hematopoietic stem cell products, NK-cell transduction and NK-cell proliferation.

Also speaking

Jennifer Rabin

Specialist Leader, Next Gen Therapy Practice • Deloitte

Frank Luppino

President & Chief Executive Officer • Remedium Bio

Joshi Venugopal

General Manager, Head of Europe for Gene Therapies and Rare Diseases • Novartis Gene Therapies

Event Info

Image

Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.
Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.